Rationale: Obesity is a major risk factor towards the development of obstructive sleep apnea, while signifi cant weight loss (both conservatively managed and surgically assisted) has a variable effect upon its severity. Differences in the effect of weight loss on obstructive sleep apnea may be due to underlying craniofacial characteristics. Objectives: To determine whether craniofacial characteristics can predict OSA treatment response to signifi cant weight loss. Methods: We analyzed craniofacial measurements from lateral cephalograms performed at baseline on 57 patients enrolled in a previously reported 2-year randomized clinical weight loss trial (laparoscopic adjustable gastric band surgery versus conservatively [dietician and very low calorie diet] treated). Group mean weight loss was ~ 13% (mean weight loss 131 to 114 kg), with corresponding reduction in mean apnea-hypopnea index (AHI) from 61 to 41 events/h. Computer assisted lateral cephalogram analysis was undertaken by three trained staff blinded to treatment. We analyzed lateral cephalogram and demographic data at baseline (cross-sectional) and change over two years (interventional) in 54 patients.
unusual. 3 Three long-term randomized controlled trials of dietary-induced weight loss indicated only small changes in AHI with a low chance of cure (AHI < 5 events/h). [4] [5] [6] Recently, we reported a randomized controlled trial of bariatric surgery, using laparoscopic adjustable gastric banding (LAGB) in 60 patients (baseline weight 131 ± 21 kg, BMI 45 ± 5 kg/m 2 , and AHI 61 ± 31 events/h). 7 After two years, the bariatric surgery group had signifi cantly more weight loss (−28 vs −5 kg) but there was no difference in change in mean AHI (−26 vs −14 events/h) compared with the conventional program (dietary and exercise advice). Only 10 patients achieved an AHI < 15 O bstructive sleep apnea (OSA) is a common condition considered a signifi cant cause of impaired quality of life plus cardiovascular, neuropsychological and perioperative morbidity, and possible mortality. Treatment is diffi cult as indicated by the wide variance (25% to 75%) in adherence to the "gold standard" therapy of continuous positive airway pressure (CPAP). 1 Other treatments such as weight loss, upper airway surgery, oral appliances, medications, nasal valves, and pacemakers may be effective in patient subgroups. Thus patient selection for each of the various treatment options is crucial but supportive data are very limited. Given that obesity and craniofacial abnormalities are two variables that contribute signifi cantly to the apnea-hypopnea index (AHI), a greater understanding of the obesity-craniofacial anatomy interplay may assist in selecting the best therapeutic option for individual patients.
Observational studies of major weight loss following bariatric surgery suggest substantial remission of OSA symptoms in up to 60% to 80%. 2 However, in studies where repeat polysomnography (PSG) was available, remission of OSA was and one patient an AHI < 5 events/h. Thus, "cure" of OSA, as defined by an AHI < 5 in this trial was rare. Moreover, the response to weight loss upon AHI was variable in both surgical and conservatively treated groups. The wide variety of responses raised question as to whether craniofacial structure influences response to weight loss.
The importance of craniofacial anatomy has been highlighted by a subgroup of the Wisconsin Sleep Cohort in which lateral cephalometry was undertaken.
8 Approximately ~25% of the AHI variance could be explained by body mass index ([BMI] with a further 25% by 6 cephalometric measurements (PV-A, PAS 1, H-MP, Gonion-SE-PNS, PAS 2 , S-N-B) out of 55 measurements tested (see Figures 1 and 2, Table 1 ). Collectively, these cephalometric measurements indicate a shorter distance between maxillary projection from the cranial base, a smaller posterior airway space, less mandibular protrusion, a narrower space between the hard palate and cranial base, and a more caudally placed hyoid bone predispose to a higher AHI. The most important cephalometric measurement was the "PV-A" (i.e., maxillary projection), which accounted for 14% of the variance; this was greater than the other 54 lateral cephalometric measurements analyzed.
We therefore hypothesized that the variance of change in AHI in our previous study 7 could be explained by craniofacial characteristics. Our aim was to determine which craniofacial measurements were associated with a response to weight loss treatment in a cohort of patients from our previously reported randomized controlled trial of two weight loss programs over two years, 7 with OSA severity as the major outcome.
METHODS
We studied subjects aged 18-60 years who were involved in a recently reported 2-year randomized controlled trial of bariatric surgical versus conservative treatment for obesity (BMI 35-55 kg/m 2 , AHI > 20 events/h) who had baseline and 2-year follow-up diagnostic polysomnograms. 7 The study was approved by the Human Ethics committees of the Alfred Hospital and Monash University in accordance with the guidelines of the National Health and Medical Research Council of Australia and the Helsinki Declaration, as revised in 2000 and 2008, respectively. All participants provided written informed consent.
Of 60 subjects randomized in the original trial, 3 patients did not obtain baseline lateral cephalograms and 3 did not attend 2-year polysomnograms; thus, data from 57 subjects were available for cross-sectional baseline analysis and 54 for interventional analysis. In this analysis, we combined both weight loss groups and used the method of weight change as a possible modifier. We then sought to determine the effect of weight change upon AHI, and asked whether craniofacial measurements were able to assist in predicting those subjects in which weight loss was effective in reducing the AHI.
Lateral cephalograms were taken while seated and awake during the baseline assessment prior to surgery. Each was taken at the same center (Alfred Hospital Radiology) using identical equipment with special attention to maintain a horizontal Frankfort line. Lateral cephalograms were analyzed using Dolphin Imaging 11 software (Dolphin Imaging, Chatsworth, CA, USA) by 3 experienced dental specialists (PD, BDM, and DJM), blinded to the results of polysomnography and change in weight. Reproducibility of measurements was undertaken by 2 trained orthodontists. Any disagreement that arose was resolved by discussion with a third expert so that consensus could be reached. Sixteen measurements were chosen based upon previously published literature 5, [8] [9] [10] as predictors of OSA ( Table 1 ) from which 6 angles (SNA, SNB, ANB and BSGo) were estimated, 5 planes (Frankfort (P-O), Nasion Vertical, Porion Vertical, Mandibular (Gn-Go) and Occlusal Plane) were identified, and 10 distances were calculated (see Table 1 ).
As the aim of the study was to look for predictors of change in % AHI in relation to % change in weight, both surgical and conventionally treated groups were combined for analysis and method of treatment was included as a covariate. Of the 60 participants recruited into the previously published study, 57 had baseline lateral cephalograms and 54 completed the study with diagnostic PSG at baseline and 2 years. 7 In view of the finding in our original study that indicated modest weight gain and loss strongly influenced the change in AHI and that greater weight loss had limited beneficial effect, we divided the trial completers (n = 54) into 2 groups: those with ≥ 5% weight loss (n = 38); and those with < 5% weight loss or weight gain (n = 16), and examined for the predictors in these subgroups.
Statistical Methods
Patients in this trial were analyzed as one group as the 2 modes of weight loss had similar effects on AHI with group of randomization a modifier. Pearson or Spearman correlation coefficients were used, as appropriate, to access univariate associations. Linear regression analysis was used to identify independent factors associated with baseline AHI, and change in AHI between baseline and 2 years. In addition a hierarchical stepwise approach was used for all analyses using demographic, anthropometric, and cephalometric measurements sequentially. 11 The whole group was divided into those with clinically significant weight loss ≥ 5%, and those with < 5% weight loss or weight gain and the analysis for prediction change in AHI was reexamined. Univariate relationships have been expressed as r-values, linear regression as R 2 values, and odds ratio ± 95% CI. All statistical analysis was performed using IBM SPSS Statistics20.
RESULTS

Cross-Sectional Associations with Baseline Diagnostic AHI (n = 57).
Baseline AHI was associated with baseline BMI and male sex independently and together provided an adjusted R 2 of 0.17 (p = 0.002), whereas there was no association with age, or a history of diabetes, hypertension, or depression. When age, sex, BMI and neck circumference were modeled together, only neck circumference was associated with baseline AHI (adjusted R 2 = 0.21, p = 0.001). Of the 16 lateral cephalogram measures, 2 were associated in a univariate manner (p < 0.05) with baseline AHI: the hyoid perpendicular to C3-retrognathion distance (r = 0.37, p = 0.004) and hyoid to posterior pharyngeal wall distance (r = 0.47, p < 0.001; Figure 1) . However, when modelled with BMI, sex, and neck circumference, neither lateral cephalometric measure above added significant variance at predicting baseline AHI. Baseline neck circumference correlated with the hyoid perpendicular to C3-retrognathion length 8 (r = 0.51, p < 0.001) and hyoid to posterior pharyngeal wall length (r = 0.60, p < 0.001). Neck circumference provided the most relevant single measure for predicting the baseline AHI.
Associations with the Percentage Change in AHI at 2 Years (n = 54)
The characteristics of these participants are shown in Table 2 . The median percentage change in AHI was −41.1% (interquartile range [IQR] −63.5 to −2.8%), and the mean was −24.7% (SD 53.7). Despite 2 outliers with > 100% increase in AHI, both of whom gained weight throughout the study and skewed the distribution to the right, the distribution of data was still appropriate for linear regression analysis with skewness and kurtosis < 2.0.
Mean percentage weight change for the combined groups was −12.4% (SD 13.7%), and median −11.6% (IQR −22 to 4.0%). As indicated in the primary manuscript, 7 we found a positive relationship between percentage change in weight and percentage change in AHI (r = 0.49, p < 0.001). We examined for preoperative variables that may influence the effect of percentage weight change on the percent change in AHI; baseline age, sex, BMI, and neck circumference did not influence this relationship. In none of the analyses did weight loss method influence the results when analysis was controlled for percentage weight loss.
Univariate correlation analysis indicated the menton -gonion (i.e., mandibular body) length (Figure 2 ) was associated with %AHI change (r = 0.45, p = 0.001) and in % weight change (r = 0.37, p = 0.006) (Figure 3) . After controlling for the percentage weight loss shorter mandibular body length was associated with a reduction in %AHI (R 2 = 0.11, p = 0.02). These effects were unchanged after additionally controlling for the subjects' height (r = 0.47, p < 0.001) and gender (r = 0.29, p < 0.001) respectively. A shorter mandibular body length was associated with greater % weight loss and greater reduction in %AHI. The second measure of mandibular length also correlated with the change in %AHI, Gn -Go, r = 0.28, p = 0.034.
Using a hierarchical regression model to assess the influence of preoperative factors on % change in AHI after controlling for % weight loss, no demographic or anthropometric measure including neck circumference, study group, or any of the lateral cephalographic measures other than menton-gonion was associated with outcomes ( Table 2 ). In addition, % weight loss (R 2 = 0.25, p < 0.001) and menton-gonion length (R 2 = 0.19, p = 0.002) were independently associated with %AHI change (R 2 = 0.31, p < 0.001).
The 54 subjects were divided into those who lost ≥ 5% (n = 38) of body weight and those who lost < 5% body weight or gained weight (n = 16). Using the same regression model the only predictor of %AHI change in those that lost more than 5% of body weight was the menton-gonion length (adjusted R 2 = 0.17, p = 0.01), and for those with weight gain or < 5% weight loss it was % weight change (adjusted R 2 = 0.27, p = 0.034). In view of the association between mandibular body length and both improved % AHI and % weight change it is possible that improved sleep with CPAP (i.e., lower AHI) was assisting better weight loss, so we tested the association between CPAP compliance (see Figures 3A and 3B) . We found Continuous variables presented as mean (standard deviation). *All changes at 2 years were significant (p < 0.001, paired student t-test). Data for the additional 3 participants in the baseline cross-sectional analysis are not shown. BMI, body mass index; AHI, apnea-hypopnea index. no association between CPAP compliance and the change in either weight or AHI.
Percentage weight loss at 2 years was associated with three independent pre-intervention predictors, namely (a) randomization to the surgical weight loss program, (b) a higher baseline BMI, and (c) a shorter mandibular body length (Me-Go, mm), and together provided an adjusted R 2 = 0.52 (Table 3) .
DISCUSSION
The main findings from this study of patients with severe OSA and severe obesity are twofold. First, using cross-sectional baseline data, 21% of the AHI variance could be explained by neck circumference and no other anthropometric, demographic, or lateral cephalographic measures provided additional explanation of variance. Second, although % weight loss correlated with % change in AHI, the only other variable that correlated with % change in AHI was the mandibular body length. However while highly statistically significant, the menton-gonion length provided an explanation for only 20% of variance. By implication, a shorter jaw was associated with a greater effect of weight loss upon the AHI. A shorter jaw was also associated with better weight loss. However shorter jaw and greater weight loss had independent influence on the reduction in AHI.
Our observation that craniofacial characteristics influence impact of weight loss upon obstructive sleep apnea expands upon previous work by Sutherland, Cistulli, and colleagues. 12 They used CT derived computerized 3D reconstructions of the upper airway in 54 males, (47 years of age, weight 108 kg, BMI 34, and AHI 41/h) to determine the effects of weight loss on the upper airway. Following a mean fall in weight of 8 kg with sibutramine and calorie restriction over 24 weeks, associated with a 16/h fall in AHI, they reported an increase in velopharyngeal airway volume (5.4 to 6.4 cm 2 ) and reduced facial (mid and lower) and parapharyngeal fat volume, while there was no change in upper airway length nor oropharyngeal or hypopharyngeal measurements. Hyoid to PNS and hyoid to C3 distances decreased, suggesting there was posterior and superior movement of the hyoid bone with weight loss. Using multiple linear regression analysis, 30% of the reduction in AHI could be explained by a reduction in airway length and the reduction in visceral abdominal fat. We were unable to find a significant relationship between baseline airway length and change in AHI. Moreover the group mean airway length did not significantly change before and after weight loss (10 vs 9.9 cm). Therefore the clinical applicability of their study in determining which patients with OSA might benefit from weight loss remains unclear. Allowing for the different techniques used (CT vs cephalogram), study populations, positions in which studies are performed (seated vs supine) and degree of weight loss, the two studies do confirm the complexity of predicting the effects of weight loss upon obstructive sleep apnea severity.
Although there are no previous randomized controlled trials of surgical weight loss, three medical weight loss trials have been undertaken. Tuomilehto et al. (n = 72, weight 97 kg, BMI 32 kg/m 2 and AHI 7/h) reported the effects of intensive healthy lifestyle change to have a greater change in weight (−11 ± 7 vs −2 ± 6 kg) and AHI (−4 ± 6 vs 0 ± 8/h), and more patients were cured at one year as defined by AHI < 5/h (63% vs 13%) than control subjects. 4 Johansson et al. (n = 63, weight 113 kg, BMI 35 kg/m 2 and AHI 37/h) reported a greater weight loss (−19 ± 4 vs 1 ± 2 kg) and lower AHI (−25 ± 17 vs −2 ± 1/h), with more cured (18% vs 0%) in the group randomized to 9 weeks of very low calorie diet compared with a control group. 5 Finally, Foster et al. (n = 264 weight 102 kg, BMI 37 kg/m 2 , and AHI 23/h) reported greater weight loss (11 ± 1 vs 1 ± 1 kg) and a greater fall in AHI (−5 ± 2 vs 4 ± 1/h) with OSA cure (36% vs 10%) in those randomized to intensive behavioral modification over one year compared with a control group. 6 Each of these trials has a greater cure than that observed in the current trial; however. populations in these medical trials had lower baseline BMI and AHI.
The fact that significant weight loss (~13% reduction) was not associated with greater numbers of OSA patients being cured may be explained by our entry criteria that generated a mean BMI at entry of 45 kg/m 2 and AHI of 60/h, both much higher than the studies detailed above. In addition our study clearly indicates a strong linear association between modest weight loss and gain with the change in AHI, but weight loss beyond 10% provided little additional benefit.
7 A nonlinear association between weight loss and obesity comorbidity change (Brander) −0.4 (−2.6 to 2.5) −0.6 (−3.8 to 2.7) Mandibular body length (Me-Go)(mm) 4.5 (2.0 to 7.0) ** 3.8 (1.1 to 6.5) ** Mandibular body length (Gn-Go)(mm) 3.8 (1.4 to 6.2) ** Not included Randomization group (medical = 1)
18.7 (−10.5 to 48) Not included % weight change at 2-years 1.9 (1.0 to 2.8) * 1.7 (0.6 to 2.8) ** *p > 0.001. **p < 0.01. Adjusted R 2 for the multivariate model = 0.31. Factors not included as they were each strongly related to factors included: Me-Go and Gn-Go, and randomization group to percentage weight change. AHI, apnea-hypopnea index; BMI, body mass index.
was well recognized and highlights the value of modest weight loss rather than the attained BMI and suggests non-mechanical (neural, metabolic, or inflammatory) factors may provide the attenuated benefit of greater weight loss.
3
Several limitations to this study include the following. Patient positioning in the cephalostat (seated rather than supine and while patient was awake) might be considered a limitation of our study; it should be borne in mind, however, that with the lateral cephalogram being taken with the mandible in a set position, whether the patient was standing or supine should have no effect on any of the bony measurements. Lateral cephalograms do not accurately measure soft tissue and are therefore of limited utility. An additional limitation of this study is an absence of a control group: either non-obese OSA or obese non OSA populations.
In conclusion, in a population with severe OSA and obesity, we have observed that the impact of weight loss upon severity of OSA, as measured by the AHI, is greater in those patients with shorter mandibular body length.
